These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 31611142)

  • 1. The immunobiology of autoimmune encephalitides.
    Alexopoulos H; Dalakas MC
    J Autoimmun; 2019 Nov; 104():102339. PubMed ID: 31611142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview of Autoimmune and Paraneoplastic Encephalitides.
    Bradshaw MJ; Linnoila JJ
    Semin Neurol; 2018 Jun; 38(3):330-343. PubMed ID: 30011413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Autoimmune Encephalitis: An Observational Monocentric Study of 38 Patients.
    Macher S; Zimprich F; De Simoni D; Höftberger R; Rommer PS
    Front Immunol; 2018; 9():2708. PubMed ID: 30524441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis.
    Wickel J; Chung HY; Platzer S; Lehmann T; Prüss H; Leypoldt F; Günther A; Scherag A; Geis C;
    Trials; 2020 Jul; 21(1):625. PubMed ID: 32641101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
    Bastiaansen AEM; van Sonderen A; Titulaer MJ
    Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiology and Prognostic Factors of Autoimmune Encephalitis].
    Prüß H
    Fortschr Neurol Psychiatr; 2016 May; 84(5):264-70. PubMed ID: 27299785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
    Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
    Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune encephalitis: recent updates and emerging challenges.
    Ramanathan S; Mohammad SS; Brilot F; Dale RC
    J Clin Neurosci; 2014 May; 21(5):722-30. PubMed ID: 24246947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study.
    Heine J; Ly LT; Lieker I; Slowinski T; Finke C; Prüss H; Harms L
    J Neurol; 2016 Dec; 263(12):2395-2402. PubMed ID: 27604620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmune encephalitis and its related-disorders].
    Yoneda M
    Rinsho Shinkeigaku; 2013; 53(11):1059-62. PubMed ID: 24291879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune encephalitis, clinical, radiological and immunological data].
    Aupy J; Collongues N; Blanc F; Tranchant C; Hirsch E; De Seze J
    Rev Neurol (Paris); 2013 Feb; 169(2):142-53. PubMed ID: 23099105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuro-Ophthalmic Features of Autoimmune Encephalitides.
    Bohm PE; Chen JJ; Bhatti TM; Eggenberger ER
    J Neuroophthalmol; 2020 Sep; 40(3):385-397. PubMed ID: 32804457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune channelopathies in paraneoplastic neurological syndromes.
    Joubert B; Honnorat J
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2665-76. PubMed ID: 25883091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
    van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
    Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing autoimmune encephalitis based on clinical features and autoantibody findings.
    Bien CG
    Expert Rev Clin Immunol; 2019 May; 15(5):511-527. PubMed ID: 30676128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune Encephalitis.
    Irani SR
    Continuum (Minneap Minn); 2024 Aug; 30(4):995-1020. PubMed ID: 39088286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limbic encephalitis associated with anti-NH2-terminal of α-enolase antibodies: A clinical subtype of Hashimoto encephalopathy.
    Kishitani T; Matsunaga A; Ikawa M; Hayashi K; Yamamura O; Hamano T; Watanabe O; Tanaka K; Nakamoto Y; Yoneda M
    Medicine (Baltimore); 2017 Mar; 96(10):e6181. PubMed ID: 28272206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulation in the acute phase of autoimmune encephalitis.
    Ciano-Petersen NL; Muñiz-Castrillo S; Vogrig A; Joubert B; Honnorat J
    Rev Neurol (Paris); 2022; 178(1-2):34-47. PubMed ID: 35000790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune therapy in autoimmune encephalitis: a systematic review.
    Nosadini M; Mohammad SS; Ramanathan S; Brilot F; Dale RC
    Expert Rev Neurother; 2015; 15(12):1391-419. PubMed ID: 26559389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-mediated encephalitis for the infectious disease specialist.
    Venkatesan A
    Curr Opin Infect Dis; 2019 Jun; 32(3):251-258. PubMed ID: 31021956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.